Skip to content

Clinical trials

Coronavirus Infections trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronavirus Infections Country / region: United States Clear all

401 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20101
20112
20151
20162
20182
20191
2020252
202173
202219
202315
20247
20259
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed238
Terminated75
Recruiting24
Withdrawn23
Unknown status18
Active, not recruiting8
No longer available6
Not yet recruiting3
Suspended3
Enrolling by invitation3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)32
ModernaTX, Inc.23
BioNTech SE10
Columbia University10
University of Minnesota8
Regeneron Pharmaceuticals7
Johns Hopkins University6
ProgenaBiome6
University of North Carolina, Chapel Hill6
Washington University School of Medicine6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronavirus Infections401
COVID-19321
Virus Diseases56
Severe Acute Respiratory Syndrome52
Coronaviridae Infections23
Respiratory Distress Syndrome23
Pneumonia22
RNA Virus Infections22
Nidovirales Infections19
Influenza, Human17

Trials

Showing 26 to 50 of 401. Each trial links to its page on Pharma Observatory.

301 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.